Verition Fund Management’s BioTelemetry, Inc. BEAT Stock Holding History

Verition Fund Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-9,152	Closed	-$660K	–	1957
2020 Q4	$660K	Buy	+9,152	New	+$479K	0.01%	594
2019 Q2	–	Sell	-3,631	Closed	-$227K	–	1540
2019 Q1	$227K	Buy	+3,631	New	+$249K	0.01%	935
2014 Q2	–	Sell	-10,040	Closed	-$101K	–	881
2014 Q1	$101K	Buy	+10,040	New	+$92.4K	0.02%	446

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Verition Fund Management's BEAT Position: Q1 2021 in Review

Verition Fund Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 9,152 shares — an estimated $660K sold.

Verition Fund Management first reported a position in BEAT in Q1 2014 and held it in 3 quarters. The position peaked at $660K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Verition Fund Management reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Verition Fund Management sold 9,152 BioTelemetry, Inc. shares in Q1 2021, an estimated $660K.
Verition Fund Management first reported a position in BioTelemetry, Inc. in Q1 2014 and held it in 3 quarters.
Verition Fund Management's BioTelemetry, Inc. position peaked at $660K in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Verition Fund Management's 13F filing for Q1 2021, filed 18 May 2021.